Füsun F. BÖLÜKBAŞ, Cengiz BÖLÜKBAŞ, MEHMET ASLAN, Esen DOLGUN, Mustafa ULUKANLIGİL

Şanlıurfa’da kronik C hepatitinde hepatit B virüs enfeksiyonu ile karşılaşma sıklığı

İmmunsuprese kronik hepatit C’lilerde artmış okkült HBV enfeksiyon bildirimleri mevcuttur. Bu çalışmada, immunsuprese olmayan ve antiviral tedavi başlanmamış kronik hepatit C’lilerde hepatit B virüsü ile karşılaşma sıklığı araştırıldı. Gereç ve yöntem: Hepatit C virüs antikoru ve hepatit C virüs RNA pozitifliği ile kronik hepatit C tanı sı almış 22 olgu (9 kadın/13 erkek, yaş ortalaması: 52±9.7 yıl) bu çalı şmaya alındı. Tüm olgularda hepatit profili mikropartikül enzim immun assay, hepatit B virüs DNA’sı ve hepatit C virüs RNA’sı ise real-time polymerase chain reaksiyonu yöntemiyle bakıldı. Bulgular: Hepatit C virüsüne bağlı kronik hepatitlilerin %68.2’sinin anti-HBc antikor pozitifliği ile hepatit B virüs enfeksiyonu ile karşılaştığı, %31.8’inin ise hepatit B virüsü ile karşılaşmamış olduğu saptandı. Hepatit C virüsüne bağlı kronik hepatitli 22 olgudan sadece 2 olguda (%9.1) hepatit B yüzey antijenin pozitif olduğu ve buna göre hepatit B virüs ile karşılaşmış olan 15 olgunun 3’ünde (%20) hepatit B virüs DNA’sının pozitifliği ile birlikte hepatit B virüsünün kalıcılığı belirlendi. Sonuç: Bizim sonuçlarımıza göre, kronik C hepatitlilerde hepatit B virüsü ile karşılaşma sık ve enfeksiyon kalıcılığı genel populasyondan daha yüksektir. Hastalığın ciddiyeti ve prognozuna katkısı olabileceğinden, özellikle de hepatit B açısından endemik bölgelerde sensitif yöntemler ile okkült hepatit B virüs enfeksiyonu araştırılmalıdır.

Anahtar Kelimeler:

Hepatit B, Hepatit C antikorları, Hepatit C, kronik, Hepatit B virüsü

The rate of hepatitis B virus exposure in subjects with chronic hepatitis C infection in Şanlıurfa

We aimed to investigate the rate of hepatitis B virus exposure in subjects with chronic hepatitis C infection who were immunocompetent and not treated with antiviral agent. Materials and methods: Twenty-two patients with chronic hepatitis C (9 female, 13 male, mean age: 52±9.7) were enrolled into this study. Hepatitis B profile was investigated by EIA and hepatitis C virus RNA and hepatitis B virus DNA by real time PCR. Results: AntiHBc antibody positivity, which suggested exposure to hepatitis B virus, was 68.2% in chronic hepatitis C patients. Four patients (18.2%) in the study group were seronegative and 3 patients (13.6%) were vaccinated against hepatitis B virus infection. Only 2 (9.1%) of 22 patients were HBsAg positive, and taking into account hepatitis B virus DNA positivity, 3 patients (20%) had replicative hepatitis B virus infection of 15 patients who were exposed to hepatitis B virus. Conclusions: According to our results, the rate of hepatitis B virus exposure and permanency of hepatitis B virus infection are higher in chronic hepatitis C patients than in the general population. Especially in regions endemic for hepatitis B virus, the occult hepatitis B virus infection, which can increase the severity or deteriorate the prognosis of the disease, should be investigated by sensitive PCR technique in patients with chronic hepatitis C virus infection.

Keywords:

Hepatitis B, Hepatitis C Antibodies, Hepatitis C, Chronic, Hepatitis B virus,

PDF

___

1. Kao JH, and Chen DS. Overview of hepatitis B and C viruses. In: Goedert JJ, Editor. Infectious causes of cancer: targets for intervention. Totowa, NJ. Humana Press Inc 2000; 313-30.
2. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995; 22: 1101-8.
3. Crespo J, Lozano JL, de la Cruz F, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994; 89: 1147-51.
4. Rodriguez M, Navascues CA, Martinez A, et al. Prevalence of antibody to hepatitis C virus in chronic HBsAg carriers. Arch Virol Suppl 1992; 4: 327-8.
5. Ishikawa T, Ichida T, Yamagiwa S, et al. High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis. J Gastroenterol Hepatol 2001; 16: 1274-81.
6. Chiaramonte M, Stroffolini T, Vian A, et al. Rate of incidence of epatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132-7.
7. Sagnelli E, Coppola N, Scolastico C, et al. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol 2001; 64: 350-5.
8. Lee DS, Huh K, Lee EH, et al. HCV and HBV coexist in HBsAg.negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV high endemic area. J Gastroenterol Hepatol 1997; 12: 855-61.
9. Colombari R, Dhillon AP, Piazzola E, et al. Chronic hepatitis in multiple virus infection: histopathological evaluation Histopathology 1993; 22: 319-25.
10. Shiratori Y, Shiina S, Zhang PY, et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 1997; 80: 2060-7.
11. Ruiz J, Sangro B, Cuende JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992; 16: 637-41.
12. Kao JH, Chen PJ, Lai MY, et al. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002; 40: 4068-71.
13. Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22-6.
14. Sheu JC, Huang GT, Shih LN, et al. Hepatitis C and B viruses in hepatitis B surface antigen.negative hepatocellular carcinoma. Gastroenterology 1992; 103: 1322-7.
15. Yotsuyanagi H, Shintani Y, Moriya K, et al. Virologic analysis of non.B, non.C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis 2000; 181: 1920-8.
16. Fukuda R, Ishimura N, Niigaki M, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus associated chronic liver disease: clinical and virological significance. J Med Virol 1999; 58: 201-7.
17. Zignego AL, Fontana R, Puliti S, et al. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon treated patients with hepatitis C virus chronic hepatitis. J Med Virol 1997; 51: 313-8.
18. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9: 243-57.
19. Brechot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34: 194-203.
20. Fan CL, Wei L, Jiang D, et al. Spontaneous viral clearance after 6.21 years of hepatitis B and C viruses coinfection in high HBV endemic area. World J Gastroenterol 2003; 9: 2012-6.
21. Liaw YF, Tsai SL, Chang JJ, et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994; 106: 1048-53.
22. Crespo J, Lozano JL, Carte B, et al. Viral replication in patients with concomitant hepatitis B and C virus infections. Eur J Clin Microbiol Infect Dis 1997; 16: 445-51.
23. Pontisso P, Gerotto M, Ruvoletto MG, et al. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 1996; 48: 157-60.
24. Pontisso P, Ruvoletto MG, Fattovich G, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529-33.
25. Boom R, Sol CJ, Salimans MM, Jansen CL, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28: 495-503.
26. Boom R, Sol CJ, Heijtink R, et al. Rapid purification of hepatitis B virus DNA from serum. J Clin Microbiol 1991; 29: 1804-11.
27. Weinberger KM, Bauer T, Bohm S, et al. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81: 1165-74.
28. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001; 34: 204-6.
29. Chan HL, Tsang SW, Leung NW, et al. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol 2002; 97: 1211-5.
30. Uchida T, Kaneita Y, Gotoh K, et al. Hepatitis C virus is frequently coinfected with serum marker negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection. J Med Virol 1997; 52: 399-405.
31. Besisik F, Karaca C, Akyuz F, et al. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol 2003; 38: 506-10.
32. Kao JH, Chen PJ, Lai MY, et al. GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. Gastroenterology 1997; 112: 1265-70.
33. Michalak TI, Pardoe IU, Coffin CS, et al. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999; 29: 928-38.
34. Değertekin H. Türkiye’de HBV epidemiyoloji ve bulaşım yolları. In: Çakaloğlu Y, Ökten A, Editors. Hepatit B ulusal uzlaşma toplantı metinleri. 1. baskı. İstanbul. İstanbul Medikal Yayıncılık 2003; 99-109.
35. Taşyaran MA. HBV enfeksiyonu epidemiyolojisi. In: Tekeli E, Balık İ, Editors. Viral Hepatit 2003. 1. baskı. Ankara. Viral Hepatit Savaşım Derneği 2003; 121-8.
36. Değertekin H. Türkiye’de kronik viral hepatitlerin seroprevalansı (1980-2003). III. Doğu-Güneydoğu Anadolu Hepato-Gastroenteroloji Sempozyumu, Erzurum 2003; 38-44.